Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Antonio Vitale,Valeria Caggiano,Eduardo Martin-Nares,Micol Frassi,Lorenzo Dagna,Pravin Hissaria,Paolo Sfriso,José Hernández-Rodríguez,Guillermo Ruiz-Irastorza,Sara Monti,Abdurrahman Tufan,Matteo Piga,Henrique A Mayrink Giardini,Giuseppe Lopalco,Ombretta Viapiana,Amato De Paulis,Paola Triggianese,Rosetta Vitetta,Alejandra de-la-Torre,Alex Fonollosa,Federico Caroni,Jurgen Sota,Edoardo Conticini,Jessica Sbalchiero,Alessandra Renieri,Giulia Casamassima,Ewa Wiesik-Szewczyk,Derya Yildirim,Andrea Hinojosa-Azaola,Francesca Crisafulli,Franco Franceschini,Corrado Campochiaro,Alessandro Tomelleri,Alicia Callisto,Mark Beecher,Sara Bindoli,Chiara Baggio,Verónica Gómez-Caverzaschi,Laura Pelegrín,Adriana Soto-Peleteiro,Alessandra Milanesi,Ibrahim Vasi,Alberto Cauli,Isabele Parente de Brito Antonelli,Florenzo Iannone,Riccardo Bixio,Francesca Della Casa,Ilaria Mormile,Carmelo Gurnari,Alessia Fiorenza,Germán Mejia-Salgado,Perla Ayumi Kawakami-Campos,Gaafar Ragab,Francesco Ciccia,Piero Ruscitti,Monica Bocchia,Alberto Balistreri,Gian Marco Tosi,Bruno Frediani,Luca Cantarini,Claudia Fabiani
DOI: https://doi.org/10.1016/j.semarthrit.2024.152430
Abstract:VEXAS syndrome is a recently described monogenic autoinflammatory disease capable of manifesting itself with a wide array of organs and tissues involvement. Orbital/ocular inflammatory manifestations are frequently described in VEXAS patients. The objective of this study is to further describe orbital/ocular conditions in VEXAS syndrome while investigating potential associations with other disease manifestations. In the present study, twenty-seven out of 59 (45.8 %) VEXAS patients showed an inflammatory orbital/ocular involvement during their clinical history. The most frequent orbital/ocular affections were represented by periorbital edema in 8 (13.6 %) cases, episcleritis in 5 (8.5 %) patients, scleritis in 5 (8.5 %) cases, uveitis in 4 (6.8 %) cases, conjunctivitis in 4 (6.8 %) cases, blepharitis in 3 (5.1 %) cases, orbital myositis in 2 (3.4 %) cases. A diagnosis of systemic immune-mediated disease was observed in 15 (55.6 %) cases, with relapsing polychondritis diagnosed in 12 patients. A significant association was observed between relapsing polychondritis and orbital/ocular involvement in VEXAS syndrome (Relative Risk: 2.37, 95 % C.I. 1.03-5.46, p = 0.048). Six deaths were observed in the whole cohort of patients after a median disease duration of 1.2 (IQR=5.35) years, 5 (83.3 %) of which showed orbital/ocular inflammatory involvement. In conclusion, this study confirms that orbital/ocular inflammatory involvement is a common finding in VEXAS patients, especially when relapsing polychondritis is diagnosed. This makes ophthalmologists a key figure in the diagnostic process of VEXAS syndrome. The high frequency of deaths observed in this study seems to suggest that patients with orbital/ocular involvement may require increased attention and more careful follow-up.